Name | 2-{[2-(4-Chlorophenoxy)ethyl]sulfanyl}-1H-benzimidazole |
---|---|
Synonyms |
2-(1H-benzimidazol-2-ylsulfanyl)ethyl 4-chlorophenyl ether
MFCD00805733 1H-Benzimidazole, 2-[[2-(4-chlorophenoxy)ethyl]thio]- 2-{[2-(4-Chlorophenoxy)ethyl]sulfanyl}-1H-benzimidazole |
Description | CLP-3094 is a potent BF3 (binding function 3)-directed inhibitor of the androgen receptor (AR). CLP-3094 inhibits AR transcriptional activity (IC50=4 μM)[1]. CLP-3094 is a selective, potent GPR142 antagonist[2]. |
---|---|
Related Catalog | |
In Vitro | CLP-3094 inhibits both an increase of intracellular Ca2+ concentration ([Ca2+]i) induced by L-tryptophan using CHO-K1 cells expressing GPR142 in the aequorin assay, and an accumulation of inositol phosphates using HEK293 cells expressing GPR142 in the SPA assay. The IC50 of CLP-3094 is 0.2 μM against 200 μM L-tryptophanfor the mouse receptor and 2.3 μM against 1 mM L-tryptophan for the human receptor in the aequorin assay. CLP-3094 also inhibits the insulin secretion from islets induced by both L-tryptophan and GPR142 agonists[2]. |
In Vivo | CLP-3094 (30, 100 mg/kg; i.p. daily from Day 0 to Day 11) consistently displayed sig-nificantly lower severity of arthritis scores than vehicletreated mice[2]. Animal Model: CAIA mouse model (Female DBA1/J mice were i.v. administered with2 mg of anti-collagen antibody, followed by i.p. administration of 50 μg of LPS)[2] Dosage: 30, 100 mg/kg Administration: I.p. daily from Day 0 to Day 11 Result: Dose-dependently reduced, by not much, the arth-ritis scores. |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 509.6±56.0 °C at 760 mmHg |
Molecular Formula | C15H13ClN2OS |
Molecular Weight | 304.794 |
Flash Point | 262.0±31.8 °C |
Exact Mass | 304.043701 |
LogP | 5.08 |
Vapour Pressure | 0.0±1.3 mmHg at 25°C |
Index of Refraction | 1.693 |